Key Record Dates Identifier: NCT02053636
Brief Title: A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer (FINESSE)

First Submitted : January 24, 2014
First Submitted that Met QC Criteria : January 31, 2014
First Posted : February 4, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : April 24, 2018
Last Update Posted : April 26, 2018